MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to compare the efficacy of mesenchymal stem cells (MSCs) with or without granulocyte colony-stimulating factor (G-CSF) mobilized peripheral stem cells (PBSC) in treating patients experiencing poor graft function or delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation.
Epistemonikos ID: 4e608c2bbbbd64f80a14dad9bfa85fa8c500daed
First added on: May 12, 2024